Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study (PET/MRCP)

University of Toronto

Status: Withdrawn

Conditions: Cholangiocarcinoma

Study type: Observational

Funder types: Other

Identifiers

NCT00604266

07-0216

Details and patient eligibility

About

To evaluate the feasibility and performance of coregistered 18F-FDG-PET/MRI in the staging of potentially respectable hilar cholangiocarcinoma.

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hilar cholangiocarcinoma assessed by conventional imaging modalities (triphasic CT scan of the liver) and thought to be potentially resectable.

Exclusion criteria

• Biliary drain inserted.
• Contraindication for MRI.
• Pregnant or breast-feeding.
• Uncontrolled diabetes (over 9.7 mmol/L).

Trial design

0 participants in 1 patient group

1

Description:

10-15 patients with potentially resectable hiilar cholangiocarcinoma